The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach.
Zollinger-Ellison syndrome (ZES) is caused by a tumor that secretes gastrin and is the most common of the malignant islet cell tumors. ZES leads to hypergastrinemia, which, in turn, causes an overproduction of gastric acid and results in complications of peptic ulcer disease. Of all the islet cell tumors, gastrinoma tumors have undergone the most extensive study, providing a model of tumor management. Increased awareness and improved biochemical and radiologic techniques mean that these disorders are being recognized in more patients. Advances in the management of gastric acid secretion and new localization methods have significantly reduced the morbidity and mortality associated with ZES. The use of intravenous proton pump inhibitors such as pantoprazole will make surgical and perioperative management more favorable for patients. Radiologic and nuclear medicine studies permit the detection of the majority of islet cell tumors and improve the ability for surgical resection. With the recent cloning of the gene for multiple endocrine neoplasia type I (MEN-I) and the recognition of tumor markers associated with the development of islet cell tumors, early detection of these tumors may someday be possible.
Pisegna
J R
JR
Division of Gastroenterology and Hepatology (111C), VA Greater Los Angeles Health Care System, CURE: VA/UCLA Digestive Diseases Center, Building 115, Room 316, 11301 Wilshire Boulevard, Los Angeles, CA 90073, USA.
D005744:Gastric Acid / Q000378:metabolism*; D015408:Gastrinoma / Q000503:physiopathology*; D006801:Humans; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D015043:Zollinger-Ellison Syndrome / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy